Funding Crisis in Cancer Research

This chapter highlights the severe funding cuts to cancer research resulting from federal decisions, particularly a significant reduction by the Defense Department for fiscal year 2025. It examines the impact of these cuts on the National Institutes of Health and the emotional turmoil faced by researchers and patients alike, including the sudden uncertainty surrounding critical research funding. Through personal stories, it underscores the profound implications for ongoing cancer treatments and clinical trials, emphasizing the urgent need for continued support in this vital field.